About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit http://www.ilgenetics.com.
About Alticor and Access Business Group
Alticor (http://www.alticor.com) is the parent company of Amway Corp., Quixtar
Inc., Access Business Group LLC and Alticor Corporate Enterprises.
Headquartered in Ada, Michigan, USA, Alticor and its affiliates offer
products, business opportunities, and product development, manufacturing
and logistic services in more than 80 countries and territories worldwide.
In its most recent financial year, the company reported worldwide sales of
more than $7.1 billion. For further information, please contact Alticor's
media information line at 616-787-7565 or e-mail Alticor's media relat
|SOURCE Interleukin Genetics|
Copyright©2008 PR Newswire.
All rights reserved